ReWalk Robotics to use AI to help people walk
Photo | Courtesy of Lifeward
A person utilizes a Lifeward mobility assistive device.
Marlborough-based ReWalk Robotics, a firm that develops assistive walking devices, has added artificial intelligence capabilities to its next prototype. The eventual goal is for the ReWalk exoskeleton technology to make predictive decisions, streamlining its ability to help individuals with neurological disabilities walk.
ReWalk is in the process of testing the viability of the sensor technology to allow autonomous decision making, according to a Tuesday press release.
The new innovation is part of ReWalk’s involvement in Israel Innovation Authority’s MAGNET incentive program, which provides funding for research and development of advanced robotic technologies. The three-year program began in May 2022.
“We have successfully demonstrated that by combining advanced sensor technology and artificial intelligence, the ReWalk Exoskeleton can detect and react to changes in terrain, leading to a potentially new generation of smart exoskeletons,” David Hexner, vice president of research and development at ReWalk, said in the press release. “We continue to advance our design objectives for the next generation of exoskeletons by making them easier and safer to use, reducing the cognitive load on the user, and broadening the use case to more activities of everyday life.”
ReWalk’s exoskeletons will be eligible for coverage under Medicare for 2024, following a Centers for Medicare & Medicaid Services ruling on the type of assistive technology.
WBJ Web Partners
Most Recent
Most Recent
0 Comments